CoChat
Cited by 165

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

ILC2-driven innate immune checkpoint mechanism antagonizes NK cell antimetastatic function in the lung

Open access
Schuijs, Martijn J., Png, Shaun, Richard, Arianne C., Tsyben, Anastasia, Hamm, Gregory, Stockis, Julie, Garcia, Celine, Pinaud, Silvain, Nicholls, Ashley, Ros, Xavier Romero, Su, Jing, Eldridge, Matthew D., Riedel, Angela, Serrao, Eva M., Rodewald, Hans-Reimer, Mack, Matthias, Shields, Jacqueline D., Cohen, E. Suzanne, McKenzie, Andrew N. J., Goodwin, Richard J. A., Brindle, Kevin M., Marioni, John C., Halim, Timotheus Y. F. · 2020 · Nature Immunology

Abstract

Metastasis constitutes the primary cause of cancer-related deaths, with the lung being a commonly affected organ. We found that activation of lung-resident group 2 innate lymphoid cells (ILC2s) orchestrated suppression of natural killer (NK) cell-mediated innate antitumor immunity, leading to increased lung metastases and mortality. Using multiple models of lung metastasis, we show that interleukin (IL)-33-dependent ILC2 activation in the lung is involved centrally in promoting tumor burden. ILC2-driven innate type 2 inflammation is accompanied by profound local suppression of interferon-γ production and cytotoxic function of lung NK cells. ILC2-dependent suppression of NK cells is elaborated via an innate regulatory mechanism, which is reliant on IL-5-induced lung eosinophilia, ultimately limiting the metabolic fitness of NK cells. Therapeutic targeting of IL-33 or IL-5 reversed NK cell suppression and alleviated cancer burden. Thus, we reveal an important function of IL-33 and ILC2s in promoting tumor metastasis via their capacity to suppress innate type 1 immunity. Pathological group 2 innate lymphoid cells (ILC2s) have mainly been implicated in allergy. Halim and colleagues demonstrate that ILC2s orchestrate a prometastatic pathway via the recruitment of eosinophils that suppress NK cell function.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41590-020-0745-y

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

See all 165

Metadata

Authors
Schuijs, M. J., Png, S., Richard, A. C., Tsyben, A., Hamm, G., Stockis, J., Garcia, C., Pinaud, S., Nicholls, A., Ros, X. R., Su, J., Eldridge, M. D., Riedel, A., Serrao, E. M., Rodewald, H.-R., Mack, M., Shields, J. D., Cohen, E. S., McKenzie, A. N. J., Goodwin, R. J. A., Brindle, K. M., Marioni, J. C., & Halim, T. Y. F.
Venue
Nature Immunology
Published
2020-08-03
Volume
21
Issue
9
Pages
998-1009
ISSN
  • 1529-2908 (ISSN-L)
  • 1529-2916
OpenAlex
W3046993567
Cited by
165
References
15
FWCI
7.73
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: ILC2-driven innate immune checkpoint mechanism antagonizes NK cell antimetastatic function in the lung. https://app.cochat.ai/papers/10.1038/s41590-020-0745-y
The paper
Schuijs, M. J., Png, S., Richard, A. C., Tsyben, A., Hamm, G., Stockis, J., Garcia, C., Pinaud, S., Nicholls, A., Ros, X. R., Su, J., Eldridge, M. D., Riedel, A., Serrao, E. M., Rodewald, H.-R., Mack, M., Shields, J. D., Cohen, E. S., McKenzie, A. N. J., . . . Halim, T. Y. F. (2020). ILC2-driven innate immune checkpoint mechanism antagonizes NK cell antimetastatic function in the lung. Nature Immunology. https://doi.org/10.1038/s41590-020-0745-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.